DFG/ SFB 1292-2
Laufzeit: 01.01.2021 - 31.12.2025
Laufzeit: 01.01.2021 - 31.12.2025
“Characterization and modulation of innate myeloid cells and platelets in hepatocellular carcinoma”. Collaborative Research Center SFB 1292 “Targeting convergent mechanisms of inefficient immunity in tumors and chronic infections.”